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Abstract
The Papua New Guinea (PNG) Department of Health introduced a ‘test and treat’malaria
case management protocol in 2011. This study assesses health worker compliance with
the test and treat protocol on a wide range of measures, examines self-reported barriers to
health worker compliance as well as health worker attitudes towards the test and treat proto-
col. Data were collected by cross-sectional survey conducted in randomly selected primary
health care facilities in 2012 and repeated in 2014. The combined survey data included pas-
sive observation of current or recently febrile patients (N = 771) and interviewer adminis-
tered questionnaires completed with health workers (N = 265). Across the two surveys,
77.6% of patients were tested for malaria infection by rapid diagnostic test (RDT) or micros-
copy, 65.6% of confirmed malaria cases were prescribed the correct antimalarials and
15.3% of febrile patients who tested negative for malaria infection were incorrectly pre-
scribed an antimalarial. Overall compliance with a strictly defined test and treat protocol was
62.8%. A reluctance to test current/recently febrile patients for malaria infection by RDT or
microscopy in the absence of acute malaria symptoms, reserving recommended antimalari-
als for confirmed malaria cases only and choosing to clinically diagnose a malaria infection,
despite a negative RDT result were the most frequently reported barriers to protocol compli-
ance. Attitudinal support for the test and treat protocol, as assessed by a nine-item mea-
sure, improved across time. In conclusion, health worker compliance with the full test and
treat malaria protocol requires improvement in PNG and additional health worker support
will likely be required to achieve this. The broader evidence base would suggest any such
support should be delivered over a longer period of time, be multi-dimensional and multi-
modal.
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Introduction
A global shift in malaria case management (MCM) practice has taken place over the past
decade. Healthcare workers in medium- to high- malaria transmission regions are moving
away from a presumptive treatment approach in which all cases of febrile illness are treated
with antimalarials towards a ‘test and treat’ approach in which new generation antimalarials
(artemisinin combination therapies or ACTs) are prescribed following parasitological confir-
mation by microscopy or rapid diagnostic test (RDT). The test and treat approach reflects cur-
rent World Health Organisation (WHO) recommendations [1] and has been formally adopted
by 96 of 97 countries with ongoing malaria transmission since its introduction [2]. Neverthe-
less, health worker compliance has often been problematic. In many countries that have
adopted the test and treat protocol, fewer than 50% of febrile cases are tested for malaria infec-
tion by microscopy or RDT [3–5] and health workers continue to report a lack of confidence in
RDT results when they are used [6–10]. Similarly, ACTs are not uniformly prescribed to con-
firmed malaria cases [11–13] and ACTs or obsolete antimalarials continue to be prescribed
presumptively or to malaria RDT negative cases [14–17].
Health worker compliance, according to the ‘systems effectiveness’ model, is one of a num-
ber of sequential components that collectively determine the proportion of clinical events that
are effectively treated by the formal health care sector [18, 19]. Other components in this
model may include (but are not limited to) treatment access, availability of medicines, patient
adherence to prescribed medication regimens and the quality of prescribed medications. Stud-
ies that have applied this approach to assess the proportion of malaria cases that receive effec-
tive treatment within a formal health care sector have reported mixed findings. An overall
systems effectiveness of 25% (meaning the formal health care sector effectively cures 25% of all
malaria infections) was calculated for children under five years in Zambia, despite relatively
high health worker compliance with malaria diagnostic testing (71%) and antimalarial pre-
scription (86%) protocols [20]. A multi-county analysis of Sub-Saharan African countries
determined systems effectiveness ranged from as low as 1% in Chad and South Sudan to at
most 60% in Botswana, Sao Tome and Principe and Uganda [18]. The relative contribution of
health worker compliance to overall systems effectiveness varied greatly between countries,
with compliance to firstline antimalarial treatment ranging from less than 10% to greater than
90%, as did the relative contribution of other components within the analysis (e.g. treatment
access and patient adherence).
Applications of the systems effectiveness approach in an MCM context (such as those
described above) have been criticised for excluding malaria cases that receive antimalarials
through non-diagnostic led pathways (e.g. presumptive prescription) and ignoring non-
malaria febrile illness (NMFI) cases that receive antimalarials [21]. Accordingly, Rao, Schellen-
berg and Ghani [21] extended the systems effectiveness model into a decision-tree tool
designed to measure a broader array of outcomes, including: correct treatment of malaria with
recommended firstline treatment, irrespective of diagnostic pathway (i.e. inclusive of presump-
tive, clinical or parasitologically confirmed malaria diagnoses); under-treatment of malaria
cases; overtreatment of NMFI with firstline antimalarials; and the overall number of febrile
patients treated appropriately (both malaria cases given firstline antimalarials and NMFI not
treated with firstline antimalarials). Findings from this extended modelling exercise, drawing
on data from a number of medium-to-high malaria transmission settings, highlight the com-
plexity, and apparent trade-offs, that occur when modelling systems effectiveness at the
broader level of febrile case management as opposed to MCM specifically. For example, provi-
sion of 100% stock of ACTs was found to predict a 28.9% point increase in the proportion of
malaria cases given an ACT; however, this also resulted in a 26% point increase in the
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proportion of NMFI cases prescribed an ACT. Thus, when considering MCM alone, 100%
ACT stock was beneficial and improved systems effectiveness, yet overall systems effectiveness
for the management of febrile illness (inclusive of malarial and non-malarial illnesses) reduced.
The systems effectiveness of MCM or febrile case management has rarely been modelled
outside of Africa and never in Papua New Guinea (PNG), a malarious country of approxi-
mately 7.3 million people in the Western Pacific. A national survey of health worker compli-
ance conducted in the 12-month period following the introduction of a ‘test and treat’ protocol
in PNG produced results illustrative of the potential tension between MCM only and extended
febrile case maangement systems effectiveness models [22]. Health worker compliance with
the test and treat MCM protocol was relatively high with 68.3% of febrile patients tested for
malaria infection by microscopy or RDT and 98.2% of parasitologically confirmed cases pre-
scribed an ACT. Nevertheless, when taking all diagnostic pathways into consideration, only
31.6% of febrile patients prescribed an antimalarial had parasitologically confirmed malaria
and only 19.3% of antimalarial prescriptions were ACTs [22]. Thus, a large proportion of
febrile cases were still inappropriately treated with antimalarials and the majority of antimalar-
ial prescriptions were for obsolete, ineffective medications.
To better understand health worker compliance with febrile case management treatment
practices more broadly, this paper aims to: a) assess health worker compliance on a range of
measures relevant to febrile case management and systems effectiveness modelling; b) elucidate
self-reported barriers to health worker compliance with current febrile case management pro-
tocols; and c) examine health worker attitudes towards current febrile case management proto-
cols. It is anticipated that the resulting findings will provide up-to-date compliance figures and
inform locally appropriate interventions to improve health worker compliance.
Method
This paper presents data from repeat cross sectional surveys of randomly selected primary
health care facilities and their respective staff, conducted in the years’ 2012 and 2014. Both sur-
veys were conducted as part of a five year evaluation of the PNG National Malaria Control Pro-
gram and followed the introduction of the ‘test and treat’ MCM protocol in late 2011. A full
description of the evaluation program, including a detailed description of the health facility
survey methodology, is presented elsewhere [23].
Study Setting
PNG is comprised of 22 provinces divided into four regions (Highlands, Momase, Southern
and New Guinea Islands) according to their geographical location. A sustained and well-
funded National Malaria Control Program has seen a reduction in the general population prev-
alence of malaria parasitaemia (as measured by light microscopy) to single digit levels [24].
However, 94% of the population are still considered at risk of malaria infection according to
the WHO [25]. The PNG Department of Health introduced a test and treat malaria protocol in
2009 [26], although it was not formally implemented until late 2011. Consistent with WHO
recommendations [1], the new protocol stipulates that all fever or suspected malaria cases be
tested for malaria infection by microscopy or RDT, introduces artemether-lumefantrine (AL)
as the new first-line treatment for uncomplicated Plasmodium falciparummalaria and AL plus
primaquine (PQ) as the new first-line treatment for uncomplicated Plasmodium vivaxmalaria
and for mixed malaria infections.
A national health worker training program was carried out in PNG pre-implementation of
the test and treat protocol. This program provided detailed instruction on mRDT use and
strongly emphasised the importance of restricting antimalarial prescription to test-confirmed
Health Worker Compliance in PNG
PLOSONE | DOI:10.1371/journal.pone.0158780 July 8, 2016 3 / 17
cases [27]. A reference manual describing the new protocol in detail was provided to each
trainee. ‘Booster’ sessions were provided in some provinces post implementation of the new
protocol, although often on an ad-hoc basis and national coverage was not achieved. The train-
ing program, reference manual and booster sessions provided relatively little detail on non-
malarial febrile case management beyond reference to an Integrated Management of Child-
hood Illness (IMCI) flowchart. No instruction on the management of non-malarial febrile ill-
ness in adolescent or adult patients was provided. The PNG National Department of Health
and the Paediatric Society of PNG issues standard treatment guidelines which outline recom-
mended management of a range of common illnesses, including malaria and non-malarial
febrile illness [28, 29]. No other training, resources or support have been specifically provided
to assist the PNG healthcare workforce comply with the test and treat protocol or manage the
increasing number of non-malarial febrile illness cases.
The majority of health services in PNG are delivered through government- and church-pro-
viders via an extensive health facility network. This network comprises seven levels of service
provision including (in ascending order from lowest level of care to highest): Level 1 (Aid
Post), Level 2 (Health Sub-Centre), Level 3 (Health Centre), Level 4 (District Hospital), Level 5
(Provincial Hospital), Level 6 (Regional Hospital) and Level 7 (National Referral Hospital).
Level 1–3 facilities largely offer primary health care services only, although inpatient admission
is possible in some Level 2 and 3 facilities for low risk procedures and/or illnesses. The PNG
health workforce largely consists of (in descending order from highest to lowest qualification):
Medical Doctors, Health Extension Officers, Nurses, Community Health Workers (CHWs)
and Rural/Medical Laboratory Assistants. A Level 1 facility is typically staffed by a single
CHW, whereas an average of 10 health workers (typically CHWs and nurses) are employed at
Level 2–3 facilities [30].
Study Sample
The study sample for each cross sectional survey consisted of up to six primary health care
facilities (Levels 1–3) from each of 20 PNG provinces in 2012 and each of 10 provinces in 2014,
using a simple random sampling procedure repeated for each survey (sampled provinces listed
in S1 Table). The sampling frame was a list of all operational primary health care facilities in
participating provinces as provided by the PNG Department of Health.
Procedure
The 2012 survey was carried out from June to November and the 2014 survey from Septem-
ber to December. A two-to-three member research team spent between one-to-five days at
each participating health facility (more time spent at larger facilities, less time at smaller facil-
ities). The research team completed a range of survey instruments at each site, including an
audit of supplies, non-participant observation of febrile case management and health worker
and patient interviews. Data presented in this paper is limited to that obtained from the non-
participant observations of febrile case management and structured, interviewer-adminis-
tered questionnaires completed with consenting health workers. Oral informed consent was
sought from the officer in charge at all participating health facilities and from all participat-
ing patients and health workers prior to observation/interview. Patients were considered eli-
gible for participation if they were outpatients, presenting with febrile symptoms or reported
a recent history of fever, had not been treated for malaria infection in the past 14 days and
were sent home at the end of their consultation (to exclude severe cases of malaria infection
from the analyses). Eligible patients were identified upon first contact with a health worker
or, if circumstances allowed, by screening in the waiting area prior to first contact with a
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health worker. Health workers were considered eligible for participation if they held a formal
health worker qualification, if they reported treating febrile patients as part of their routine
clinical duties and if the test and treat protocol had been implemented in their respective
health facility at the time of interview.
Ethics Statement
The study was approved and granted ethical clearance by the Medical Research Advisory Com-
mittee (MRAC) of PNG (MRAC No. 10.12; 26 Feb 2010). The PNGMRAC approved the use
of oral consent rather than written consent as the study took place in the frame of routine mon-
itoring and evaluation of the PNG National Malaria Control Program conducted on behalf of
the National Department of Health. Written consent was not considered appropriate in this
context. The provision of oral consent was recorded on all participant questionnaires/observa-
tion checklists. Oral consent was obtained from caregivers/guardians on behalf of minors/chil-
dren enrolled in the study.
Measures
The non-participant observation of febrile case management was undertaken by a trained
research officer who passively observed the management of fever patients from the point of
initial contact with a health professional until service exit or admission onto a treatment
ward. During the course of this observation, the research officer recorded whether specified
actions did or did not occur as well as the content of specific actions (e.g. whether an antima-
larial was prescribed and, if yes, what type of antimalarial) on a structured checklist. The
checklist was divided into discrete sections including diagnosis, prescription and treatment
counselling and was informed by input from experienced medical- and medical research-
professionals. The health worker interview consisted of open and closed questions pertaining
to education, work experience and supervision, type and utility of any malaria-related train-
ing received (inclusive of training on new treatment policy), knowledge, attitudes and prac-
tices relevant to malaria case management and experiences implementing the new treatment
policy.
Data Analysis
All data were double entered into DMSys version 5.1 (Sigma Soft International). Stata/SE ver-
sion 12 was used for statistical analysis. Univariate analysis was performed to describe the char-
acteristics of the various samples and for calculating 95% confidence intervals (CIs) on selected
measures. Differences on repeat measures across time were examined by chi-square or two-
tailed t-tests as appropriate. The calculation of all CIs was adjusted for possible clustering at
the health facility level by using the Stata ‘svy’ command in which health facilities were defined
as the primary sampling unit.
Patients were only included in the analyses for the non-participant observation sample if
they attended a health facility that had RDTs or operational microscopy and AL and PQ in
stock. Thus, the necessary resources to comply with the test and treat protocol were available
in all cases. An antimalarial prescription was considered correct (i.e. compliant with protocol)
if: AL was prescribed to P. falciparum cases; AL + PQ was prescribed to P. vivax or mixed
malaria infection cases; or if AL or AL + PQ was prescribed to any malaria ‘positive’ case in
which the species type was not identified. The response options for each ‘attitudinal’ statement
were ‘agree’, ‘disagree’ and ‘don’t know’. ‘Don’t know’ responses were categorised as ‘incorrect’
in the analysis.
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Results
Study Samples
Non-participant observations. The case management of 771 febrile patients from 56 pri-
mary healthcare facilities met the inclusion criteria. Three healthcare facilities were sampled in
both surveys. All other healthcare facilities were included in one survey only (37 in 2012 and
22 in 2014). Table 1 presents selected patient characteristics by survey year as well as the loca-
tion of the respective health facility in which treatment was observed. As shown, a majority of
participants were from the Momase (34.5%) or Southern (24.4%) regions. Participation was
relatively evenly split by sex and age grouping.
Health worker interviews. A total of 265 health workers from 88 primary healthcare facil-
ities met the inclusion criteria. Four healthcare facilities were sampled in both surveys. All
other healthcare facilities were included in one survey only (a total of 46 in each year). Table 2
presents selected health worker characteristics by survey year as well as the location of their
respective health facilities. A majority of participants were from the Momase (34.3%) or South-
ern (28.7%) region, were female (56.2%) and held a CHW qualification (64.9%). The mean age
of participants was 40.1 years (SD 10.1) and the mean number of years in employment was
17.5 (SD 11.2).
Compliance
Observed compliance. Table 3 presents the total number and type of antimalarial pre-
scriptions (none, correct or incorrect) by malaria diagnostic test result (no test, malaria posi-
tive, malaria negative) per survey year. Out of a total of 169 incorrect antimalarial
prescriptions, 78.1% (132/169) were due to the exclusive use of non-recommended antimalari-
als (e.g. chloroquine), 17.2% (29/169) were due to a failure to combine PQ with an AL prescrip-
tion when treating a non-P. falciparummalaria infection, 2.4% (4/169) were for combining PQ
with AL when treating a P. falciparum infection and a further 2.4% (4/169) were for combining
AL with an obsolete antimalarial. A full description of the types of antimalarial prescription by
diagnostic test result is presented in S2 Table.
The range of health worker compliance indicators, as informed by data in Table 3, are listed
in Table 4. As shown, 74.2% (53+240/395) of current/recent febrile patients received a malaria
diagnostic test in 2012 as compared to 81.1% (69+236/376) in 2014, a statistically significant
increase (x2(1) = 5.33, p = 0.021). Of those patients with confirmed malaria, 67.9% (36/53)
received the correct antimalarial/s in 2012 as compared to 63.8% (44/69) in 2014 (x2(1) = 0.23,
p = 0.632). All confirmed malaria cases were prescribed an antimalarial (i.e. no under treat-
ment was evident). When all diagnostic pathways are taken into account (i.e. a presumptive,
Table 1. Location and selected characteristics of the febrile patient sample.
Characteristic 2012 (n = 395) 2014 (n = 376) Overall (n = 771)
Location Southern 32.4% 16.0% 24.4%
Highlands 20.8% 16.0% 18.4%
Momase 30.4% 38.8% 34.5%
Islands 16.4% 29.2% 22.7%
Sex Male 46.6% 53.2% 49.8%
Female 53.4% 46.8% 50.2%
Age <5 yrs 41.4% 36.8% 39.2%
5–14 yrs 23.0% 25.3% 24.1%
15+ yrs 35.6% 37.9% 36.7%
doi:10.1371/journal.pone.0158780.t001
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clinical or confirmed diagnosis of malaria), the correct antimalarial was prescribed in 26.5%
(41/41+113) and 45.0% (45/45+56) of malaria cases in 2012 and 2014, respectively. This
increase reached statistical significance (x2(1) = 9.14, p = 0.002). The percentage of current/
recent febrile patients prescribed an antimalarial despite testing negative for malaria infection
decreased, to a statistically significant level, from 20.0% (1+46/240) in 2012 to 10.6% (1+25/
236) in 2014 (x2(1) = 9.02, p = 0.011). Compliance with prescription protocols irrespective of
diagnostic pathway (i.e. prescribing the recommended antimalarial/s to patients diagnosed
with presumptive, clinical or confirmed malaria and not prescribing any antimalarial/s to
NMFI patients) increased from 70.9% (48+4+36+193+1/395) to 85.1% (65+44+210+1/376)
over the same time period. Compliance with both diagnostic and prescription protocols
increased from 58.0% (36+193/395) to 67.8% (44+210/376). Increases in these last two mea-
sures of compliance reached statistical significance (x2(1) = 22.57, p<0.001 & x2(1) = 7.99,
p = 0.005, respectively).
In addition, 21.3% (95% CI 11.8, 35.6) of febrile patients were advised to sleep under a mos-
quito net in 2012 as compared to 20.4% (95% CI 8.0, 43.1) in 2014 and 21.0% (95% CI 13.0,
32.1) overall. This difference between time-periods failed to reach a level of statistical signifi-
cance (x2(1) = 0.23, p<0.632).
Self-reported compliance. 80.8% (214/265) of health workers reported managing at least
one febrile patient in the two weeks prior to survey. The total number of febrile patients report-
edly managed was 5856 (2012, n = 3319; 2014, n = 2537) at a median of 15 (IQR 22) patients
per participant (the comparative figures for 2012 and 2014 were 18.5 (IQR 32) and 12 (IQR
18), respectively). According to health worker self-report, 65.9% of these patients were tested
Table 2. Location and selected characteristics of the health worker sample.
Characteristic 2012 (n = 153) 2014 (n = 112) Overall (n = 265)
Location Southern 39.9% 13.4% 28.7%
Highlands 19.6% 18.8% 19.3%
Momase 21.6% 51.8% 34.3%
Islands 18.9% 16.0% 17.7%
Sex Male 41.8% 46.4% 43.8%
Female 58.2% 53.6% 56.2%
Qualiﬁcation Dr 0.7% 0% 0.4%
HEO 3.3% 6.3% 4.5%
Nurse 26.1% 29.8% 29.8%
CHW 69.2% 64.9% 64.9%
Pharmacist 0.7% 0% 0.4%
Age (in years) 39.9 (SD 10.0) 41.8 (10.2) 40.1 (SD 10.1)
Work experience (in years) 16.2 (SD 11.5) 19.3 (SD 10.7) 17.5 (SD 11.2)
doi:10.1371/journal.pone.0158780.t002
Table 3. Frequency of antimalarial prescription by diagnostic test result.
Diagnostic Test Result Antimalarial Prescription
2012 2014
N Nil Correct Incorrect N Nil Correct Incorrect
No test 102 48 4 50 71 65 0 6
Malaria + 53 0 36 17 69 0 44 25
Malaria - 240 193 1 46 236 210 1 25
Total 395 241 41 113 376 275 45 56
doi:10.1371/journal.pone.0158780.t003
Health Worker Compliance in PNG
PLOSONE | DOI:10.1371/journal.pone.0158780 July 8, 2016 7 / 17
for malaria infection by RDT or microscopy (58.2% & 76.0% in 2012 and 2014, respectively),
34.6% were prescribed an antimalarial (28.4% & 42.6%, respectively) and 27.7% were provided
malaria prevention advice (23.0% & 33.9%, respectively).
Table 5 presents the percentage of health workers who reported at least one instance of non-
compliance in the two weeks prior to survey. Overall, health workers were most likely to report
at least one instance of failing to provide malaria prevention advice (89.7% of the total), fol-
lowed by failing to test for malaria infection by RDT or microscopy (40.2%), providing an
incorrect antimalarial prescription (32.3%) and providing an antimalarial to a RDT negative
patient (23.7%). The variations observed in the percentage of health workers reporting at least
one instance of non-compliance across the two time periods reached a level of statistical
Table 4. Compliance indicators.
Compliance Indicator 2012 2014 Overall
% (95% CI) % (95% CI) % (95% CI)
Febrile patients tested for malaria infection by RDT or
microscopy
74.2% (58.7,
85.3)
81.1% (65.0,
90.8)
77.6% (67.2,
85.4)
Conﬁrmed malaria cases prescribed recommended
antimalarial/s
67.9% (46.9,
83.5)
63.8% (49.6,
79.5)
65.6% (54.2,
75.4)
Conﬁrmed malaria cases not prescribed any antimalarial 0% 0% 0%
Presumptive/clinical/conﬁrmed malaria cases prescribed
recommended antimalarial/sa
26.5% (12.9,
46.6)
45.0% (35.8,
54.5)
33.7% (22.9,
46.6)
Conﬁrmed non-malaria febrile illness cases prescribed an
antimalarial
20.0% (9.7,
36.7)
10.6% (5.6,
19.2)
15.3% (9.2,
24.5)
Compliance with prescription protocols irrespective of
diagnosis typeb
70.9% (55.1,
82.9)
85.1% (78.0,
90.2)
77.8% (68.7,
84.9)
Compliance with diagnostic and prescription protocolsc 58.0% (43.6,
71.2)
67.8% (55.7,
77.9)
62.8% (53.4,
71.3)
a. A presumptive malaria case is deﬁned as any patient prescribed the recommended ﬁrstline antimalarial/s,
despite no conﬁrmatory diagnosis. A clinical malaria case is deﬁned as any patient prescribed the
recommended ﬁrstline antimalarial/s, despite testing negative for malaria via a diagnostic test.
b. Presumptive/clinical/conﬁrmed malaria cases given the recommended ﬁrstline antimalarial/s and NMFI not
treated with antimalarials. In this calculation, presumptive and clinical malaria diagnoses in which the
recommended ﬁrstline antimalarial/s is prescribed are assumed to be correct.
c. In this calculation, presumptive and clinical diagnosis of malaria are assumed to be incorrect (non-
compliant with protocol)
doi:10.1371/journal.pone.0158780.t004
Table 5. Percentage of health workers self-reporting at least one instance of non-compliance in the two weeks prior to survey.
Form of Non-Compliance % Self-Reporting (95% CI)a
2012 2014 Overall
(n = 120) (n = 94) (n = 214)
Failed to test for malaria infection by RDT/MS 46.7 (35.1, 58.6) 31.9 (20.6, 45.8) 40.2 (31.6, 49.5)
Provided incorrect antimalarial prescriptionb 37.1 (23.4, 53.2) 26.4 (14.7, 42.8) 32.3 (23.0, 43.2)
Provided an antimalarial prescription to a RDT negative patient C 23.9 (14.0, 37.7) 23.5 (13.7, 37.2) 23.7 (16.0, 33.6)
Failed to provide malaria prevention advice 88.3 (76.8, 94.5) 91.5 (84.1, 95.6) 89.7 (83.7, 93.7)
a, Self-reporting non-compliance with at least one febrile/recently febrile patient in the two weeks prior to survey.
b, Analysis limited to those participants who reported providing at least one antimalarial prescription in two weeks prior to survey (n = 161).
C, Analysis limited to those participants who reported at least one malaria negative patient as conﬁrmed by RDT or microscopy in the two weeks prior to
survey (n = 190).
doi:10.1371/journal.pone.0158780.t005
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significance on only one measure: failing to test for malaria infection by RDT or microscopy
which decreased from 46.7% in 2012 to 31.9% in 2014 (x2(1) = 4.77, p = 0.029).
Self-Reported Barriers to Compliance
Tables 6 and 7 present self-reported reasons why participating health workers did not test at
least one febrile/recently febrile patient for malaria infection by RDT in the two weeks prior to
survey or why AL was not prescribed (when antimalarial prescriptions were given). The most
widely reported reason for not conducting a RDT was the absence of fever at the time of diag-
nosis or perceived absence of other common malaria symptoms. Nil or low RDT stock was the
next most widely reported reason. Five participants reported that it was not their duty to com-
plete RDTs and that they expected the patient to receive the diagnostic test at another point
during the clinical consultation.
The most frequently reported reason for not prescribing the correct antimalarial medication
was that the recommended firstline antimalarial medications were thought to be reserved for
RDT postive cases only. In other words, when health workers chose to prescribe an antimalarial
to a RDT negative patient or a patient who had not received a RDT they often believed it was
inappropriate to prescribe the recommended firstline antimalarial regimen in these circum-
stances and opted for obsolete antimalarials instead.
The most frequently reported reason for prescribing an antimalarial medication to at least
one RDT negative patient in the two weeks prior to survey was a clinical diagnosis of malaria
despite the negative RDT result (n = 33), followed by patient insistence (n = 1) and as a pro-
phylactic measure (n = 1). The most frequently reported reason for not providing malaria pre-
vention advice to at least one febrile/recently febrile patient in the two weeks prior to survey
was “too busy or insufficient time” (n = 32), followed by “forgot” (n = 7) or a belief that the
provision of such advice was unnecessary (n = 7).
Health workers were further asked if they had experienced any problem(s) implementing
the test and treat malaria protocol. Overall, 44.4% (95% CI 37.3, 51.7) of health workers
Table 6. Frequency of self-reported reasons for not using a RDT.
Reasons 2012 2014 Overall
(n = 37) (n = 27) (n = 64)
Absence of fever/malaria symptoms 22 19 41
Nil/low RDT stock 6 4 10
RDT completed elsewhere 1 4 5
Inadequate training 3 0 3
Patient refused test 2 0 2
Don’t use RDT at ﬁrst presentation 2 0 2
Too busy 1 0 1
doi:10.1371/journal.pone.0158780.t006
Table 7. Frequency of self-reported reasons for prescribing non-recommended antimalarial medication.
Reasons 2012 2014 Overall
(n = 21) (n = 10) (n = 31)
Recommended medication reserved for RDT+ cases 16 5 21
Clinical judgement 3 1 4
Recommended medication out of stock 1 3 4
Preserve limited supply of recommended medication 0 1 1
Deplete existing supply of obsolete medication 1 0 1
doi:10.1371/journal.pone.0158780.t007
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reported that they had experienced at least one problem, with a modest and statistically insig-
nificant increase across time periods: 43.2% (95% CI 34.4, 52.6) and 46.0% (95% CI 35.2, 57.1)
in 2012 and 2014, respectively (x2(1) = 0.19, p = 0.665). The most frequently reported problem
was perceived knowledge gaps in understanding the full protocol (n = 55), followed by a
reported lack of confidence in one or more aspects of the new protocol (n = 27), typically the
perceived reliability of RDT results or perceived effectiveness of AL. Shortages of either RDTs
or AL were the third most frequently reported problem (n = 24).
Health Worker Attitudes towards the Test and Treat Protocol
Health workers were presented with nine statements designed to measure attitudinal support
for the test and treat protocol. Table 8 lists the nine statements, the ‘correct’ response (i.e. a
response considered supportive of the test and treat protocol) for each statement and the per-
centage of participants who responded correctly. As shown, the percentage of participants
responding correctly increased on seven out of the nine statements between 2012 and 2014 and
decreased on two (‘advising patients how best to avoid mosquito bites is a good use of clinical
time’ and ‘telling patients when to take their medication is less important if written instructions
are provided’). The reported changes in the percentage of participants who provided a correct
response reached statistical significance on two statements: “All patients who present with
fever or suspected malaria should be tested for malaria infection by microscopy or RDT”
(90.2% & 98.2% in 2012 & 2014, respectively; x2(1) = 6.92, p = 0.009); and “In most cases, com-
bination therapy is the most effective treatment for malaria infection” (51.6% & 67.0% in 2012
& 2014, respectively; x2(1) = 6.24, p = 0.012). Overall, the mean number of correct statements
(out of nine) was 6.8 (SD 1.5). The mean number of correct statements in 2012 and 2014 were
6.6 (SD 1.5) and 7.1 (SD 1.4), respectively; a statistically significant increase, t(262) = -2.961,
p = 0.003.
Overall, 87.0% (95% CI 77.4, 92.9) of health workers reported that malaria treatment had
improved as a result of the test and treat protocol. An increase was evident across time-periods
Table 8. Health worker responses to nine attitudinal statements.
Statement ‘Correct’
Response
% (95% CI) of Participants’ Providing
Correct Response
2012 2014 Overall
All patients who present with fever or suspected malaria should be tested for malaria
infection by microscopy or RDT
Agree 90.2 (83.8,
94.3)
98.2 (93.4,
99.5)
93.6 (89.6,
96.1)
In most cases, chloroquine is an effective treatment for uncomplicated malaria infection Disagree 47.7 (39.1,
56.4)
55.4 (43.8,
66.4)
50.9 (44.3,
57.6)
Advising patients how best to avoid mosquito bites is a good use of clinical time Agree 77.8 (70.7,
83.6)
76.8 (64.4,
85.8)
77.4 (71.1,
82.6)
In most cases, clinical diagnosis is just as accurate as microscopy or RDT in detecting
malaria infection
Disagree 68.6 (57.3,
78.1)
77.7 (68.3,
84.9)
72.5 (64.9,
78.9)
Fever patients who test negative for malaria infection should still be provided with
antimalarial medication as a precautionary measure
Disagree 68.0 (56.9,
77.4)
74.1 (63.4,
82.6)
70.6 (62.7,
77.4)
It is important to distinguish between vivax and falciparum infection when treating
uncomplicated malaria
Agree 79.7 (72.6,
85.4)
87.4 (78.2,
93.0)
83.0 (77.8,
87.1)
Telling patients when to take their medication is less important if written instructions are
provided
Disagree 84.3 (78.2,
89.0)
83.9 (76.3,
89.4)
84.2 (79.7,
87.8)
In most cases, combination therapy is the most effective treatment for malaria infection Agree 51.6 (42.2,
60.9)
67.0 (57.3,
75.4)
58.1 (51.1,
64.8)
Malaria patients are less likely to complete their medication if the importance of doing so is
not clearly communicated to them
Agree 89.5 (83.4,
93.6)
91.1 (83.9,
95.2)
90.2 (85.9,
93.3)
doi:10.1371/journal.pone.0158780.t008
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with 84.0% (95% CI 67.9, 92.9) and 91.1% (95% CI 79.6, 96.4) of health workers reporting
improvement in 2012 and 2014 (respectively), although this did not reach statistical signifi-
cance (x2(1) = 2.84, p = 0.092). The most frequently reported reason for improvement was a
perceived increase in the accuracy of malaria diagnosis with the introduction of RDTs
(n = 110). This was followed by a perceived improvement in treatment outcome as a result of
the new antimalarial (n = 84) and a perceived reduction in malaria cases (n = 65). The latter
was reported as either a result of fewer malaria cases in the community or as a result of more
accurate diagnosis (meaning fewer malaria cases were recorded).
Discussion
Compliance with core MCM ‘test and treat’ protocols was observed in the majority of cases
with 77.6% of patients tested for malaria infection by RDT or microscopy and 65.6% of con-
firmed malaria cases prescribed the correct antimalarial/s (and all confirmed malaria cases pro-
vided an antimalarial of some description). In addition, only 15.3% of febrile patients who
tested negative for malaria infection were subsequently prescribed an antimalarial. Encourag-
ingly, statistically significant improvements were identified on all but one of the compliance
measures between 2012 and 2014, indicating that PNG health workers have become increas-
ingly compliant with the test and treat protocol in the two-to-three year period immediately
following its introduction. These figures compare favourably with health worker compliance
rates internationally [3–5, 15, 31, 32].
Observed compliance with recommend antimalarials was less impressive when all diagnos-
tic pathways were considered (i.e. inclusion of presumptive/clinical malaria diagnosis), with
only 33.7% of patients diagnosed with malaria by any means provided the correct antimalarial.
This finding indicates that PNG primary healthcare workers prescribe less effective, obsolete
antimalarials to presumptively/clinically diagnosed malaria patients as compared to confirmed
malaria cases, a practice recorded elsewhere [15, 32]. The majority of those health workers who
reported prescribing an incorrect antimalarial stated as much, with 67.7% choosing to reserve
recommended firstline antimalarials for confirmed malaria cases only. Similarly, while overall
compliance with prescription protocols was relatively high when diagnostic pathway was not
considered (77.8%), compliance with a strictly defined ‘test and treat’ protocol (all febrile cases
tested by RDT or microscopy, correct antimalarial only prescribed to confirmed malaria cases,
no antimalarial prescription to test negative cases) was much lower (62.8%). These findings
suggest that there is still considerable room for improvement in health worker compliance in
routine diagnostic testing and antimalarial prescribing practices and support the contention by
Rao et al that systems effectiveness modelling based on strict MCM parameters may obscure
limitations in broader febrile case management practice [21].
Health worker attitudes towards the test and treat protocol were largely positive with 84.0%
of participants reporting MCM to have improved as a result of the new test and treat protocol
in 2012, increasing to 91.1% in 2014. Similarly, on a nine-item measure designed to assess atti-
tudinal support for the test and treat protocol, the majority of responses were ‘correct’ (or sup-
portive) at both time-points and the mean number of ‘correct’ responses improved over time.
The attitudinal data reflect the relatively high and increasing health worker compliance with
febrile case management protocols. What is uncertain at this stage is whether health worker
compliance in PNG will increase further with continued exposure to the test and treat protocol,
whether health worker compliance is now at or approaching a maximum level achievable given
current (limited) health worker supports or whether these initial compliance gains may deteri-
orate over time. In support of the latter two possibilities was the finding that a consistent and
not in-significant percentage of participants reported at least one instance of non-compliance
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in the two weeks prior to survey in both 2012 and 2014. A large number of barriers to compli-
ance were identified by health workers, but four in particular were widely reported. These
included: a reluctance to test current/recently febrile patients for malaria infection by RDT or
microscopy in the absence of acute malaria/fever symptoms; reserving recommended firstline
antimalarials for confirmed malaria cases only; choosing to clinically diagnose a malaria infec-
tion, despite a negative RDT result; and having too little time to provide malaria prevention
advice. In addition, just under half of the health worker sample (44.4%) reported experiencing
at least one problem implementing the test and treat protocol, a percentage that increased
slightly across time (43.2% vs. 46.0%, respectively). The most frequently reported problem was
a perceived knowledge gap in understanding the full protocol and a lack of confidence in one
or more aspects of the protocol, which was typically the perceived reliability of RDT results.
The reported reluctance to use a RDT with recently febrile patients who do not present with
overt symptoms of malaria infection as well as a continued distrust in RDT negative results are
issues of particular concern. For while health worker compliance with RDT use increased over
the two survey periods, and antimalarial prescription decreased, it is possible that these trends
may reverse in a context of declining malaria transmission as is the case in PNG [24]. As fewer
and fewer current/recently febrile patients present to health services, or test positive for malaria
infection when they do, then the utility of routine RDT testing may become less apparent and
compliance with diagnostic protocols may decline. Health worker distrust of RDT negative
results has been widely documented internationally [6–10] and is likely exacerbated by a dearth
of cheap and reliable diagnostic point of care tests for other febrile illnesses [33]. In the absence
of a reliable means of differential diagnosis, or intensive training to support differential diagno-
sis, then health workers may revert to a previous practice of clinically diagnosing malaria or
they may adopt other ‘convenience’ diagnoses and prescription practices, as may already be
evident by high rates of antibiotic prescription in RDT negative cases [34–36]. Adhering to
RDT results has been proven safe in the PNG context [37], so the continued distrust suggests
further clinical education is warranted. The current practice of reserving recommended first-
line antimalarials for confirmed malaria cases is perhaps less concerning as it is more amenable
to correction through drug procurement and supply mechanisms. If the supply of obsolete
antimalarials is systematically decreased then the prescription of recommended antimalarials
can only increase (at least relative to other prescriptions and assuming a consistent or increas-
ing supply) as has previously been observed [3]. Having said this, availability of recommend
antimalarials is not in itself sufficient to ensure correct prescription practice [3, 38].
A main aim of this study was to identify potential interventions to improve health worker
compliance with the test and treat malaria protocol in Papua New Guinean primary health
care facilities. Findings from this study suggest the greatest gains in health worker compliance
would be achieved by (in order of importance): promoting uniform prescription compliance
with recommended firstline antimalarials irrespective of whether a patient is diagnosed with
malaria presumptively, by RDT or microscopy or clinically despite a negative RDT result; pro-
moting routine testing for malaria infection by RDT or microscopy for all febrile or recently
febrile patients irrespective of the decreasing malaria burden in PNG; and discouraging the
prescription of antimalarials to RDT negative patients who are not clinically suspected of
severe malaria, at least during an initial clinical consultation. How best to increase health
worker compliance in these areas remains an open question. A review of health worker support
interventions in low resource settings concluded that multiple means of support are almost
always necessary to improve health worker performance [39]. Available evidence largely sup-
ports this contention in a malaria-specific context. Short-term or one-off interventions
designed to improve MCM often produce limited or mixed results [40–42], while an increasing
number of studies have demonstrated statistically significant and sustained improvement in
Health Worker Compliance in PNG
PLOSONE | DOI:10.1371/journal.pone.0158780 July 8, 2016 12 / 17
MCM through longer-term health worker support interventions. These include: a two day
training, multiple interactive workshops, and supportive SMS collectively delivered over a
14-month period [43]; a two-three day training, regular on-site clinical mentorship and sup-
portive SMS collectively delivered over a 6-month period [44]; a three week ‘integrated man-
agement of infectious disease’ training, followed by two one week booster sessions (12- and
24-weeks post training) and on-site support two days a month for a nine-month period [45];
and supportive SMS sent over a six-month period [46]. Thus, a longer-term health worker sup-
port program, possibly consisting of varied components, may be most likely to produce signifi-
cant and sustained change in health worker malaria/febrile case management practice in PNG.
Consistent with a previous recommendation by Galactionova et al [18], greater gains in overall
health worker compliance may also be achieved if the focus of any such intervention is on all
components of MCM (e.g. diagnostic, prescription and treatment counselling practices) rather
than a specific aspect (e.g. non-prescription of antimalarial medication to RDT negative
patients).
The findings reported in this study are also notable for the remarkable similarity between
observed and self-reported compliance figures. Health workers self-reported testing 65.9% of
febrile patients for malaria infection by RDT or microscopy, prescribing an antimalarial to
34.6% of febrile patients and giving malaria prevention advice to 27.7%. The comparative fig-
ures for observed (unmatched) febrile patients were 77.6%, 33.7% and 21.0%, respectively.
Health worker self-report could be, therefore, a potentially reliable proxy indicator of MCM
practice and possibly more accurate than patient self-report. Patient self-report has previously
been found to be a reasonable proxy measure of diagnostic and prescription MCM practice in
PNG, but a poor proxy measure of treatment counselling (e.g. the provision of malaria preven-
tion advice) [47]. The sensitivity and specificity of health worker self-report as a proxy measure
of MCM would need to be established before reliance conclusions can be drawn; the data pre-
sented in this paper suggest this may be an exercise worth exploring.
The reported study was not without limitation. Participating clinicians were aware that they
were being observed and may have altered their clinical practice accordingly. The expected
effect of any such bias would be towards perceived ‘better’ practice (i.e. higher compliance).
Similarly, health workers may have been reluctant to self-report non-compliance, or at least
the full extent of non-compliance, in response to interview questions. Nevertheless, the high
degree of convergence between observed and self-reported measures of compliance improves
confidence in the reported findings. The reported compliance figures were based on medica-
tion type only and could potentially be lower if drug dosage had been taken into consideration.
Finally, the sample excluded secondary-care and private-sector health facilities and may not be
representative of malaria case management in these settings.
Conclusion
Health worker compliance with a test and treat malaria protocol is higher in PNG relative to
other malarious countries at a similar stage of protocol implementation and has improved sig-
nificantly in the two-to-three year period following its introduction. Nevertheless, compliance
was far from perfect on a number of measures and the level of compliance varied depending on
whether strict MCM criteria were applied or not. The study identified a small number of persis-
tent barriers to health worker compliance and the findings raise the possibility that health
worker compliance with the test and treat protocol may now be at a maximum threshold or
may even decline without further intervention. Key focal areas for intervention should include
the uniform prescription of recommended firstline antimalarials irrespective of diagnostic
pathway, routine testing for malaria infection by RDT or microscopy for all febrile or recently
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febrile patients and the non-prescription of antimalarials to RDT negative patients. The
broader evidence base would suggest any such intervention be delivered over a longer period of
time (e.g. six months or more), be multi-dimensional (e.g. focus on all three areas, rather than
any one) and multi-modal.
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